download:
  setup: geo
  download: wget
  id: GSE143363
  description: ~
  keyword: ~
  ignore_hto: yes
  fname:
    protein: GSE143363_count_matrix.tsv.gz
    other: GSE143363_cell_metadata.tsv.gz
    rna: GSE143363_count_matrix.tsv.gz
  wlink:
    protein: https://www.ncbi.nlm.nih.gov/geo/download/?acc=GSE143363&format=file&file=GSE143363%5Fcount%5Fmatrix%2Etsv%2Egz
    other: https://www.ncbi.nlm.nih.gov/geo/download/?acc=GSE143363&format=file&file=GSE143363%5Fcell%5Fmetadata%2Etsv%2Egz
    rna: https://www.ncbi.nlm.nih.gov/geo/download/?acc=GSE143363&format=file&file=GSE143363%5Fcount%5Fmatrix%2Etsv%2Egz
load:
  protein:
    transpose: no
    separate_samples: no
    keyword: ~
    class: csv
    h5key: ~
    altexp: ~
    access: ~
    drop: ~
    keep: '"_ADT"'
    coldata: ~
    cells: ~
    replace: ~
    features: ~
    column: ~
    sample_groups: ~
    samples:
      file: metadata
      key: cell_id
      value: sample
  rna:
    transpose: no
    separate_samples: no
    keyword: ~
    class: csv
    h5key: ~
    altexp: ~
    access: ~
    drop: '"_ADT"'
    keep: ~
    coldata: ~
    cells: ~
    replace: ~
    features: ~
    column: ~
    sample_groups: ~
    samples:
      file: metadata
      key: cell_id
      value: sample
metadata:
  doi: doi.org/10.1158/2159-8290.CD-19-0710
  description: 'Primary human AML specimens were obtained from apheresis product,
    peripheral blood, or bone marrow of patients with AML. Patients included: one
    hundred consecutive patients with newly diagnosed AML and no prior therapy who
    were prescribed VEN+AZA at our institution and had taken at least one dose of
    either therapy. An AML patient who achieved remission but ultimately relapsed
    from the venetoclax plus azacitidine therapy was chosen for this CITE-seq analysis.'
  tissue: BM
  species: Homo sapiens
  alias: Pei_2020
  genome_build: GRCh38
